Skip to main content

Dementia: Medical Treatments

Volume 458: debated on Wednesday 14 March 2007

To ask the Secretary of State for Health whether her Department recommends anti-cholinisterease inhibitors for the treatment of people with dementia displaying challenging behaviour symptoms. (126452)

The National Institute for Health and Clinical Excellence clinical guideline states that anti-cholinesterase inhibitors are recommended as options in the management of people with Alzheimer’s disease of moderate severity only.

It also recommends that people with dementia who develop non-cognitive symptoms or behaviour that challenges should be offered a pharmacological intervention in the first instance only if they are severely distressed or there is an immediate risk of harm to the person or others.